Beta Amyloid Antibody
Dezamizumab (GSK 2398852) is a fully humanized recombinant monoclonal immunoglobulin G1 (IgG1) antibody specifically targeting the serum amyloid P component (SAP), a protein universally found in all types of amyloid deposits, and it possesses potential anti-amyloid activity by triggering an immunotherapeutic mechanism for the clearance of amyloid fibrils through macrophage-mediated phagocytosis, which can be applied in the research of amyloid light-chain (AL) amyloidosis and other systemic amyloid diseases.
Product Specifications
Product Name Alternative
Anti-Serum Amyloid P/SAP Reference Antibody (Dezamizumab), GSK2398852, GSK 2398852
Target
Beta Amyloid
Clonality
Recombinant
Conjugation
Unconjugated
Field of Research
Neuroscience
Concentration
5.28 mg/mL
Purity
95.00% (May vary between batches)
Molecular Weight
145.82 kDa
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
Human Protein Hook homolog 3, HOOK3 ELISA Kit
Human Protein Hook homolog 3, HOOK3 ELISA Kit
Human Protein Hook homolog 3, HOOK3 ELISA Kit
Human Protein Hook homolog 3, HOOK3 ELISA Kit
6-Fluoro-3-methyl-1-benzothiophene-2-sulfonyl chloride